Good Post Marketing Study Practice (GPSP) is a Japanese regulatory framework that governs post-marketing studies for pharmaceuticals. GPSP provides standards for the planning, execution and reporting of clinical and observational trials after drug approval.&nbsp;The framework promotes patient safety, maintains the product quality and allows accurate evaluations of drug efficacy and adverse events during the post-marketing stage. <h2 style="text-align: justify">How Good Post Marketing Study Practice (GPSP) Works?</h2> GPSP offers structured guidance to post-marketing studies conducted in Japan. This includes re-examinations, spontaneous adverse events reporting and observational studies.&nbsp;Pharmaceutical companies must develop a study protocol that is clear, set objectives, choose study sites and collect data systematically.&nbsp;The Pharmaceuticals and <a href="https://www.ddregpharma.com/what-are-medical-devices">Medical Devices</a> Agency reviews study plans and reports to ensure that they comply with GPSP standards.&nbsp;This framework ensures post-marketing safety data and efficacy are reliable, traceable and suitable for regulatory assessment. <h2 style="text-align: justify">When Is Good Post Marketing Study Practice (GPSP) Applied?</h2> <ul type="disc"><li style="font-size: 16px">Post-marketing surveillance studies required by the Japanese <a href="https://www.ddregpharma.com/what-is-the-pharmaceuticals-and-medical-devices-agency-of-japan">PMDA</a></li><li style="font-size: 16px">Re-examination studies for newly approved drugs</li><li style="font-size: 16px">Observational or epidemiological research evaluating long-term safety or efficacy</li><li style="font-size: 16px">Safety data collection from routine clinical use that informs risk management and labelling updates</li></ul> <h2 style="text-align: justify">What Evidence Do Regulators Expect in Good Post Marketing Study Practice (GPSP) Studies?</h2> <ul type="disc"><li style="font-size: 16px">Study design and protocol, including endpoints, statistical analysis and study protocol</li><li style="font-size: 16px">Monitoring and Quality Control Procedures</li><li style="font-size: 16px">Data collected should be accurate and complete</li><li style="font-size: 16px">Processes of ethical approval and informed consent</li><li style="font-size: 16px">Reporting adverse events as soon and accurately as possible</li><li style="font-size: 16px">Final report supporting safety and efficacy conclusion after post-marketing</li></ul> The GPSP allows regulators make informed decisions about safety warnings, changes in labelling, or risk minimisation. <h3 style="text-align: justify">What are the Challenges in Good Post Marketing Study Practice (GPSP) Compliance?</h3> <ul type="disc"><li style="font-size: 16px">Ensuring rigorous monitoring and verification across multiple sites</li><li style="font-size: 16px">Maintaining consistent and accurate documentation</li><li style="font-size: 16px">Adapting study protocols to emerging safety signals or new indications</li><li style="font-size: 16px">Meeting strict timelines for study execution, reporting, and regulatory submission</li><li style="font-size: 16px">Aligning GPSP requirements with global post-marketing standards</li></ul> <h4 style="text-align: justify">Why Good Post Marketing Study Practice (GPSP) Matters?</h4> GPSP enhances post-marketing drug pharmacovigilance through reliable data collection, reporting and analysis for safety and efficacy. It helps protect patients, facilitates regulatory decisions, and allows for continuous improvement in marketed pharmaceuticals. Compliance is important for manufacturers to maintain their credibility, reduce risk and meet PMDA requirements efficiently. <h5 style="text-align: justify">DDReg Capabilities</h5> DDReg offers end-to-end assistance for GPSP compliant post-marketing studies conducted in Japan. The team prepares regulatory reports, develops study protocol, provides advice on site selection, monitoring, and accuracy, and ensures data traceability. Contact the DDReg team now.

Learn what Good Post-Marketing Study Practice (GPSP) is, PMDA requirements, compliance challenges, and how pharma companies ensure post-marketing safety in Japan.

What Is Good Post Marketing Study Practice (GPSP)?